Chemomab Therapeutics CMMB Ratios (2011-2026)

NASDAQ CMMB
$1.19 +0.01 (+0.85%)
As of: Oct 21, 2026 · 1:28 PM EDT
Reported Financials

Chemomab Therapeutics Quarterly Ratios

Periods 41 quarters
Latest Jun 2026

Chemomab Therapeutics ratios data for the quarter ended Jun 2026. These financial ratios cover 41 quarters of results from Jun 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Jun2011 Sep2011 Dec2011 Jun2012 Sep2012 Dec2012 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
EBT Margin
EBIT Margin
EBITDA Margin
Operating Margin
Net Margin
FCF Margin
Efficiency
Assets AverageAssets Avg.
68.98M65.90M62.65M58.67M53.30M46.64M39.04M31.93M26.13M22.78M20.08M16.28M17.72M18.93M14.89M11.97M11.75M13.09M12.81M11.02M
Equity AverageEquity Avg.
66.78M63.49M59.35M54.54M48.23M40.42M32.09M24.97M20.02M17.52M15.16M11.66M13.15M14.93M11.97M10.05M10.47M11.78M11.51M9.69M
Leverage & Solvency
Interest Coverage RatioInterest Cover
Times Interest Earned
Valuation
Price to EarningsP/E
20.52
Price to BookP/B
1.931.280.960.820.641.030.660.700.580.430.831.301.372.521.982.261.100.961.061.34
Enterprise Value
88.54M63.51M40.91M32.41M17.77M-2.67M-2.27M-11.29M-10.96M-12.54M-4.80M0.23M2.92M19.86M9.99M12.51M2.34M1.50M3.25M4.96M
EV to EBIT
-1.380.030.41
Market Capitalization
126.29M78.69M54.74M42.30M28.51M37.22M18.49M15.30M10.41M7.24M11.08M12.96M22.30M34.13M20.55M21.87M12.40M11.87M11.29M11.65M
Return Ratios
Return on Sales [ROS]ROS
Return on Capital Employed [ROCE]ROCE
-49.88%-67.24%-26.85%-36.56%-52.18%-70.64%-99.27%-131.48%-100.15%-50.79%22.22%65.09%53.37%-134.97%-172.03%-191.37%-206.56%-112.89%-125.32%-155.93%
Return on Assets [ROA]ROA
2.67%-30.32%-25.34%-32.89%-45.80%-59.27%-80.17%-103.58%-79.61%-40.01%17.46%48.20%40.28%-112.03%-146.07%-168.52%-186.57%-100.15%-114.43%-133.97%
Return on Equity [ROE]ROE
2.76%-31.47%-26.75%-35.39%-50.61%-68.39%-97.53%-132.45%-103.93%-52.03%23.12%67.29%54.27%-142.07%-181.80%-200.86%-209.45%-111.26%-127.31%-152.39%

Chemomab Therapeutics Ratios API

Pull Chemomab Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CMMB&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY